If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Correspondence to Dr Kerry Dwan, Centre for Reviews and Dissemination, University of York, York, UK; Kerry.dwan{at}york.ac.uk A systematic review identifies, appraises and synthesises all the ...

Background and Objectives As teaching technology advances, medical education is increasingly using digital mediums and exploring instructional models such as the flipped classroom and blended learning ...

5 Red Colaborativa Pediátrica de Latinoamérica (LARed Network), Montevideo, Uruguay During the early phase of the pandemic, school closures were one of the non-pharmaceutical interventions (NPIs) ...

Correspondence to Dr Igho J Onakpoya, Nuffield Department of Primary Care Health Sciences, University of Oxford, Centre for Evidence-Based Medicine, Oxford OX2 6GG, UK; igho.onakpoya{at}phc.ox.ac.uk ...

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

Correspondence to Dr Marleen Kunneman, Medical Decision Making, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands; kunneman{at}lumc.nl For too many people, ...

Numerous drivers push specialist diagnostic approaches down to primary care (‘diagnostic downshift’), intuitively welcomed by clinicians and patients. However, primary care’s different population and ...

Correspondence to Austin L Johnson, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA; austin.johnson14{at}okstate.edu Objective To assess the methodological and reporting ...

Correspondence to Dr Mark H Ebell, Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, 125 Miller Hall, UGA Health Sciences Campus, Athens, GA 30602, USA; ...

Correspondence to Dr Mohammad Hassan Murad, Evidence-based Practice Center, Mayo Clinic, Rochester, MN 55905, USA; murad.mohammad{at}mayo.edu When decision makers make a recommendation based on ...

Accelerating Food and Drug Administration (FDA) product approval to market based on surrogate markers in the absence of proven efficacy creates a risk of adverse outcomes for affected patients, even ...